Is DMPWW or EPRT a better dividend investment in 2026?

DMPWW currently yields 2000000.00% with a 5% 5-year dividend growth rate. EPRT yields 3.92% with 5% growth. The better choice depends on your goal: DMPWW offers higher current income.

What is the dividend yield difference between DMPWW and EPRT?

DMPWW has a forward dividend yield of 2000000.00% ($2.00/share annually). EPRT yields 3.92% ($1.21/share annually). The yield gap is 1999996.08 percentage points.

Home › Compare › DMPWW vs EPRT

DMPWW vs EPRT: Dividend Comparison 2026

DMPWW yields 2000000.00% · EPRT yields 3.92%● Live data

vsPost on X →

After 10 years · $10,000 invested · DRIP enabled

🏆 DMPWW wins by $1.6247481716182984e+23M in total portfolio value

INVESTMENT

TIME HORIZON10 years

DMPWW

● Live price

2000000.00%

Share price

$0.00

Annual div

$2.00

5Y div CAGR

-50%

Payout ratio

50%

After 10 yrs · $10,000 · DRIP

Portfolio value

$1.6247481716182984e+23M

Annual income

$147,608,011,402,949,780,000,000,000,000.00

Full DMPWW calculator →

EPRT

● Live price

3.92%

Share price

$30.77

Annual div

$1.21

5Y div CAGR

29%

Payout ratio

50%

After 10 yrs · $10,000 · DRIP

Portfolio value

$63.4K

Annual income

$12,840.73

Full EPRT calculator →

Portfolio growth — DMPWW vs EPRT

📍 DMPWW pulled ahead of the other in Year 1

Annual dividend income

🛡️

Recession Test — Did They Cut Dividends?

How each stock treated shareholders during the 3 biggest crises of the last 20 years

Crisis Period	DMPWW	EPRT
2008–2009 GFC	— No data	— No data
2020 Q1–Q2 COVID	— No data	— No data
2022 Q4 Rate Hike	— No data	— No data

Based on dividend payment history. "Increased" = dividend grew during crisis. "Maintained" = held within 3%. "Cut" = reduced by more than 3%.

📅

Dividend Calendar Overlap

Combined, DMPWW + EPRT cover 0 of 12 months — good coverage

Jan

—

Feb

—

Mar

—

Apr

—

May

—

Jun

—

Jul

—

Aug

—

Sep

—

Oct

—

Nov

—

Dec

—

DMPWW pays

EPRT pays

Both pay

Neither

💰

Tax Bracket Optimizer

Which stock is actually better after tax? Adjust your rate to find out.

DMPWW

Annual income on $10K today (after 15% tax)

$170,000,000.00/yr

After 10yr DRIP, annual income (after tax)

$125,466,809,692,507,310,000,000,000,000.00/yr

EPRT

Annual income on $10K today (after 15% tax)

$332.87/yr

After 10yr DRIP, annual income (after tax)

$10,914.62/yr

At 15% tax rate, DMPWW beats the other by $125,466,809,692,507,310,000,000,000,000.00/year in after-tax income after 10 years on $10,000

⚖️

Lazy Portfolio Split Optimizer

What's the optimal mix of DMPWW + EPRT for your $10,000?

DMPWW: 50%EPRT: 50%

100% EPRT50/50100% DMPWW

Portfolio after 10yr

$8.123740858091492e+22M

Annual income

$73,804,005,701,474,890,000,000,000,000.00/yr

Blended yield

90.85%

📊

Analyst Conviction Gap

Where Wall Street is most bullish on EPRT right now

DMPWW

No analyst data

Altman Z

-32.8

Piotroski

3/9

EPRT

Analyst Ratings

Strong

Buy

Hold

Sell

Consensus: Buy

Price Target

$35.50

+15.4% upside vs current

Range: $33.00 — $37.00

Altman Z

1.8

Piotroski

5/9

Analyst ratings via FMP. Altman Z-Score: >3.0 safe, 1.81–3.0 grey zone, <1.81 distress. Piotroski: 7–9 strong, 0–3 weak.

🏛️

Copy Congress — What Are Politicians Buying?

Senate & House STOCK Act disclosures (last 90 days)

DMPWW buys

EPRT buys

No recent congressional trades found for DMPWW or EPRT in the last 90 days.

STOCK Act mandates disclosure within 45 days of transaction. Data via FMP.Full tracker →

MetricDMPWWEPRT

Forward yield	2000000.00% ✓	3.92%
Annual dividend / share	$2.00 ✓	$1.21
Payout ratio	50%	50%
1-year div growth	0%	0%
5-year div CAGR	-50%	29% ✓
Portfolio after 10y	$1.6247481716182984e+23M	$63.4K ✓
Annual income after 10y	$147,608,011,402,949,780,000,000,000,000.00 ✓	$12,840.73
Total dividends collected	$1.6146053563276882e+23M	$37.9K ✓
Payment frequency	quarterly	quarterly
Sector	Stock	REIT

Year-by-year: DMPWW vs EPRT ($10,000, DRIP)

Year	DMPWW Portfolio	DMPWW Income/yr	EPRT Portfolio	EPRT Income/yr	Gap
1← crossover	$100,010,700	$100,000,000.00	$11,205	$505.18	+$100.00M → DMPWW
2	$467,446,731,075	$467,339,719,626.17	$12,672	$682.46	+$467446.72M → DMPWW
3	$1,021,215,363,816,662	$1,020,715,195,814,411.90	$14,490	$930.48	+$1021215363.80M → DMPWW
4	$1,043,112,617,104,109,200	$1,042,019,916,664,825,300.00	$16,786	$1,282.69	+$1043112617104.09M → DMPWW
5	$498,482,143,759,731,400,000	$497,366,013,259,430,040,000.00	$19,753	$1,791.56	+$498482143759731.38M → DMPWW
6	$111,599,275,650,097,780,000,000	$111,065,899,756,274,860,000,000.00	$23,677	$2,541.64	+$111599275650097776.00M → DMPWW
7	$11,738,678,336,351,557,000,000,000	$11,619,267,111,405,953,000,000,000.00	$29,008	$3,672.99	+$11738678336351557632.00M → DMPWW
8	$583,674,362,697,175,100,000,000,000	$571,113,976,877,278,900,000,000,000.00	$36,463	$5,425.08	+$583674362697175072768.00M → DMPWW
9	$13,894,210,989,607,547,000,000,000,000	$13,269,679,421,521,570,000,000,000,000.00	$47,238	$8,221.57	+$1.3894210989607547e+22M → DMPWW
10	$162,474,817,161,829,840,000,000,000,000	$147,608,011,402,949,780,000,000,000,000.00	$63,385	$12,840.73	+$1.6247481716182984e+23M → DMPWW

DMPWW vs EPRT: Complete Analysis 2026

DMPWW — Stock

Kintara Therapeutics, Inc., a clinical stage drug development company, focuses on developing and commercializing anti-cancer therapies to treat cancer patients. It is developing two late-stage, Phase III-ready therapeutics, including VAL-083, a DNA-targeting agent for the treatment of drug-resistant solid tumors, such as glioblastoma multiforme, as well as other solid tumors, including ovarian cancer, non-small cell lung cancer, and diffuse intrinsic pontine glioma; and REM-001, a late stage photodynamic therapy for the treatment of cutaneous metastatic breast cancer, basal cell carcinoma nevus syndrome, and access graft failure in hemodialysis patients. Kintara Therapeutics, Inc. has a strategic collaboration with Guangxi Wuzhou Pharmaceutical (Group) Co. Ltd. to manufacture and sell VAL-083 in China. The company was formerly known as DelMar Pharmaceuticals, Inc. and changed its name to Kintara Therapeutics, Inc. in August 2020. Kintara Therapeutics, Inc. was incorporated in 2009 and is headquartered in San Diego, California.

Full DMPWW Calculator →

EPRT — REIT

Essential Properties Realty Trust, Inc., a real estate company, acquires, owns, and manages single-tenant properties in the United States. The company leases its properties to middle-market companies, such as restaurants, car washes, automotive services, medical and dental services, convenience stores, equipment rental, entertainment, early childhood education, grocery, and health and fitness on a long-term basis. As of December 31, 2021, it had a portfolio of 1, 451 properties. The company qualifies as a real estate investment trust for federal income tax purposes. It generally would not be subject to federal corporate income taxes if it distributes at least 90% of its taxable income to its stockholders. The company was founded in 2016 and is headquartered in Princeton, New Jersey.

Full EPRT Calculator →

📬

Get this DMPWW vs EPRT comparison by email

Save your analysis + weekly dividend insights. Free forever.

More comparisons

DMPWW vs SCHD DMPWW vs JEPI DMPWW vs O DMPWW vs KO DMPWW vs MAIN

⚠️ Educational purposes only. Not financial advice. Congressional trades sourced from SEC STOCK Act filings via FMP. Past performance does not guarantee future results.